| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| lomustine ema | 1.93 | 0.3 | 3330 | 36 | 13 |
| lomustine | 0.39 | 0.2 | 799 | 77 | 9 |
| ema | 1.13 | 0.1 | 4448 | 28 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| lomustine ema | 1.57 | 0.2 | 2802 | 8 |
| lomustine macmillan | 1.72 | 0.5 | 6814 | 11 |
| lomustine manufacturer | 1.87 | 0.4 | 1589 | 68 |
| lomustine maximum dose | 1.58 | 0.1 | 1550 | 24 |
| lomustine emc | 0.97 | 0.3 | 8571 | 82 |
| lomustine avastin glioblastoma | 0.77 | 0.2 | 6927 | 99 |
| lomustine and bevacizumab | 1.75 | 0.5 | 8892 | 54 |
| lomustine package insert | 0.96 | 0.2 | 2091 | 22 |
| lomustine medac | 0.33 | 0.8 | 8284 | 100 |
| lomustine and avastin for gbm | 1.08 | 0.3 | 6200 | 90 |
| lomustine mechanism of action | 0.37 | 0.4 | 4186 | 84 |
| lomustine administration | 0.43 | 0.9 | 1199 | 13 |
| lomustine avastin | 1.49 | 0.3 | 8740 | 19 |
| lomustine and cns tumors | 1.23 | 0.3 | 2308 | 47 |
| lomustine and bevacizumab glioblastoma | 1.23 | 0.7 | 2969 | 4 |
